| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 11/24/2011 | WO2011144335A1 Stable ready to use injectable paracetamol formulation |
| 11/24/2011 | WO2011088333A3 Solid-forming local anesthetic formulations for pain control |
| 11/24/2011 | WO2011087494A3 Use of a virucidal preparation on an area of the face for prevention of transmission or contraction of viral illnesses, or to shorten the duration of, or lessen the severity of viral illnesses |
| 11/24/2011 | WO2011084513A3 Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers |
| 11/24/2011 | WO2011084458A3 Polymer-based compositions and methods for treatment of peritoneal disorders |
| 11/24/2011 | WO2011075516A3 Active scaffolds for on-demand drug and cell delivery |
| 11/24/2011 | WO2011040973A3 Tnf-immunoconjugates with fibroblast activation protein antibodies and methods and uses thereof |
| 11/24/2011 | WO2010144265A3 Ipamorelin diacetate injection and infusion solutions |
| 11/24/2011 | WO2010142400A3 Chitosan oligosaccharide-based compositions |
| 11/24/2011 | WO2010118213A3 Particles for delivery of nucleic acids and related devices and methods |
| 11/24/2011 | WO2010052466A8 Pharmaceutical aerosol composition |
| 11/24/2011 | WO2002030467A9 Pharmaceutical composition containing honey for the treatment of wounds |
| 11/24/2011 | US20110288462 Haemostatic wound care article |
| 11/24/2011 | US20110288363 Biologically Enhanced Irrigants |
| 11/24/2011 | US20110288238 Enhanced transport using membrane disruptive agents |
| 11/24/2011 | US20110288182 Health characteristic dulce de leche confection compositions and flavored milk |
| 11/24/2011 | US20110288181 Preparations of biologically active substances with enlarged surface based on amphiphilic copolymers |
| 11/24/2011 | US20110288172 Dermatological compositions and methods |
| 11/24/2011 | US20110288146 Directly compressible granular microcrystalline cellulose based, excipient, manufacturing process and use thereof |
| 11/24/2011 | US20110288099 Compositions with reduced hepatotoxicity |
| 11/24/2011 | US20110287466 Aggregate-Free Urate Oxidase for Preparation of Non-Immunogenic Polymer Conjugates |
| 11/24/2011 | US20110287114 Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition |
| 11/24/2011 | US20110287102 Chain extenders |
| 11/24/2011 | US20110287083 Bioabsorbable Composition and Coatings Including Same |
| 11/24/2011 | US20110287073 Emulsion Concentrate |
| 11/24/2011 | US20110287049 Prevention and treatment of amyloidogenic diseases |
| 11/24/2011 | US20110287035 Method and composition for hyperthermally treating cells |
| 11/24/2011 | US20110287033 Use of ferritin to treat iron disorders |
| 11/24/2011 | US20110286948 Bacterial cellulose film and uses thereof |
| 11/24/2011 | US20110286929 Multivalent constructs for therapeutic and diagnostic applications |
| 11/24/2011 | US20110286923 Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases |
| 11/24/2011 | US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 11/24/2011 | DE102008006791B4 Transdermales Therapeutisches System mit Harnstoff-Komponente und Verfahren zu dessen Herstellung Transdermal therapeutic system with urea component and method for its production |
| 11/24/2011 | CA2837059A1 Cancer treatment |
| 11/24/2011 | CA2799942A1 Pharmaceutical composition containing solifenacin |
| 11/24/2011 | CA2799928A1 Topical formulation for a jak inhibitor |
| 11/24/2011 | CA2799773A1 Novel self-reactive arms and prodrugs comprising same |
| 11/24/2011 | CA2799666A1 Stable ready to use injectable paracetamol formulation |
| 11/24/2011 | CA2799633A1 Improved anti-serum albumin binding variants |
| 11/24/2011 | CA2799480A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases |
| 11/24/2011 | CA2799202A1 Compositions and methods for treatment of autoimmune and other diseases |
| 11/24/2011 | CA2798084A1 Drug delivery devices for delivery of ocular therapeutic agents |
| 11/24/2011 | CA2794614A1 Biosynthetic proline/alanine random coil polypeptides and their uses |
| 11/23/2011 | EP2388270A2 Modulation of SIRPa - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 11/23/2011 | EP2388264A1 Compound retained in tumor |
| 11/23/2011 | EP2388016A1 Non-viral nucleic acid molecules delivery systems |
| 11/23/2011 | EP2387999A1 Histidine-containing solution for transfection and/or injection of nucleic acids and uses thereof |
| 11/23/2011 | EP2387993A1 Orally disintegrating tablets of zolmitriptan and process for preparing the same |
| 11/23/2011 | EP2387991A1 Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| 11/23/2011 | EP2387985A1 Process for producing o/w microemulsion preparation for external application |
| 11/23/2011 | EP2387579A1 Polypeptides for specific targeting to otx2 target cells |
| 11/23/2011 | EP2387421A1 Compounds comprising n-formyl-methionine residues and tumor-targeting peptides |
| 11/23/2011 | EP2387420A2 New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein |
| 11/23/2011 | EP2387419A2 New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor |
| 11/23/2011 | EP2387394A2 Transdermal administration of tamsulosin |
| 11/23/2011 | EP2387390A2 Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation |
| 11/23/2011 | EP2387389A1 Formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules |
| 11/23/2011 | EP2377926A9 Chondrocyte-like cell, and method for producing same |
| 11/23/2011 | EP2293791B1 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
| 11/23/2011 | EP2197492B1 Novel taxoid-based compositions |
| 11/23/2011 | EP2035008B1 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals |
| 11/23/2011 | EP2021797B1 Compositions of n-ý2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl¨-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 11/23/2011 | EP1864659B1 Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 11/23/2011 | EP1716868B1 Anti-inflammatory analgesic for external use |
| 11/23/2011 | EP1670433B1 Transdermal pharmaceutical formulation for minimizing skin residues |
| 11/23/2011 | EP1644941B1 Method of manufacturing magnetic nanoparticles having improved magnetic properties |
| 11/23/2011 | EP1137439B2 Stabilization of rapamycins or derivatives of rapamycins |
| 11/23/2011 | EP0948358B2 Stable liquid interferon formulations |
| 11/23/2011 | CN1897978B Assembly of gas-filled microvesicle with active component for contrast imaging |
| 11/23/2011 | CN1671351B NSAID-containing topical formulations that demonstrate chemopreventive activity |
| 11/23/2011 | CN102257133A Chondrocyte-like cell, and method for producing same |
| 11/23/2011 | CN102256999A Efficient transport into white blood cells |
| 11/23/2011 | CN102256998A Novel transporter constructs and transporter cargo conjugate molecules |
| 11/23/2011 | CN102256626A Delivery system for delivery of a substance into the oral cavity |
| 11/23/2011 | CN102256625A Mono- and di-peg il-10 production |
| 11/23/2011 | CN102256624A Coating material for solid medicine and solid medicine formed with same |
| 11/23/2011 | CN102256620A Immunotherapeutic compositions for the treatment of alzheimer's disease |
| 11/23/2011 | CN102256604A Aqueous oral preparation of stable amlodipine |
| 11/23/2011 | CN102256600A Ceramic honeycomb structure skin coating |
| 11/23/2011 | CN102256599A Flowable pharmaceutical depot |
| 11/23/2011 | CN102256597A Method for producing powder containing nanoparticles of insoluble drug, powder produced thereby and pharmaceutical composition containing same |
| 11/23/2011 | CN102251317A Preparation method of electrospun fibers with controllable drug release |
| 11/23/2011 | CN102250920A Soluble and mutational BAFF protein and its coding gene and application |
| 11/23/2011 | CN102250441A Nanoparticle of hyperbranched star-like polylactic acid-poly [2-(N,N-dimethyl amino) ethyl methacrylate] block polymer prepared with volatilization process and method thereof |
| 11/23/2011 | CN102250440A Hyperbranched star-shaped polylactic acid-polymethacrylic acid 2-dimethylamino acetate block polymer nanoparticle prepared by dialysis method and method |
| 11/23/2011 | CN102250365A PH-sensitive reduction responsive nanogel and preparation method thereof |
| 11/23/2011 | CN102250346A Biodegrable cationic polymemers |
| 11/23/2011 | CN102250342A PEG/mPEG (Polyethylene Glycol) multi-carboxyl chemical modifying agent connected with citric acid, preparation method and application thereof in modification of toluylene compound |
| 11/23/2011 | CN102250298A Brain-targeted polymer drug delivery material and preparation method thereof |
| 11/23/2011 | CN102250277A Macromolecular polymer capable of carrying medicine and used for embolism |
| 11/23/2011 | CN102250254A Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) fusion protein, its preparation and applications |
| 11/23/2011 | CN102250253A Fusogenic peptide containing thrombin fragment |
| 11/23/2011 | CN102250252A Gastrin-releasing peptide (GRP) guided fusion protein |
| 11/23/2011 | CN102250251A Polyethylene glycol derivative of enkephalin analogue |
| 11/23/2011 | CN102250222A Peptide capable of transporting DNA to target neurocytes and brain |
| 11/23/2011 | CN102250205A Preparation method of fatty acyl-RGD (Arg Gly Asp) induced docetaxel target liposome and antitumor activity thereof |
| 11/23/2011 | CN102249943A Flavor-enhancing amide compounds |
| 11/23/2011 | CN102247604A Angiotensin II receptor 1 type polypeptide-vector vaccine and application thereof |
| 11/23/2011 | CN102247603A Method for promoting epidermal growth factor transdermal drug delivery of protein drug |
| 11/23/2011 | CN102247602A Super-molecular hydrogel double-medicament carrier and preparation method as well as application thereof |